Related Experiment Video
Updated: Jul 29, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
G0/G1 arrest and S phase inhibition of human cancer cell lines by inositol hexaphosphate (IP6)
Y M El-Sherbiny1, M C Cox, Z A Ismail
1Department of Clinical Pathology University of Minia School of Medicine, Egypt.
Background:
Inositol hexaphosphate (InsP6 or IP6) has shown a striking anti-cancer activity in both in vivo and in vitro models. In an attempt to elucidate the mechanism(s) underlying the anti-neoplastic potential of IP6, we investigated its effect on cell cycle progression of MCF-7 estrogen receptor (ER)-positive and MDA-MB 231 ER-negative human breast cancer cell lines and HT-29 human colon cancer cells.
Methods:
The anti-proliferative effect of IP6 was evaluated using dual-parameter flow cytometric measurements of DNA content, versus the incorporation of 5-bromo-2-deoxyuridine (BrdU) to determine cells actively synthesizing DNA. Combined analysis of the expression of cell cycle-related proteins, proliferation marker Ki-67 and proliferating cell nuclear antigen (PCNA) versus DNA content were used to determine the amount of proliferating cells in each phase, engaged in cell cycle transit.
Results:
After 3 days of treatment with 5 mM IP6, S-phase, as estimated by BrdU uptake, was significantly decreased in all three cell lines (p = 0.002). MCF-7 and HT-29 cells accumulated in the G0/G1 range of DNA contents (p = 0.002 and p = 0.001, respectively). MDA MB-231 cells transiently accumulated in G0/G1 only after 2 days (p = 0.01). There was a significant decrease in the percentage of Ki-67 expression in IP6-treated cells, from 82.8+/-3.0% to 66.8+/-4.2% in MCF-7 (p = 0.007), from 93.4+/-4.6% to 71.7+/-3.3% in MDA-MB 231 (p = 0.004), and from 95.2+/-1.2% to 73.5+/-2.5% in HT-29 cells (p = 0.002) respectively. PCNA expression levels were also significantly decreased by IP6 in all three cell lines (MCF-7 p = 0.0007; MDA-MB 231 p = 0.0006; HT-29 p = 0.0001).
Conclusion:
These results show that IP6 controls the progression of cells through the cycle by decreasing S- phase and arresting cells in the G0/G1-phase of the cell cycle. A significant decrease in the expression of proliferation markers indicated that IP6 disengaged cells from actively cycling. Further investigations of cell cycle regulators may lead us to a better understanding of the mechanism(s) of the anti-neoplastic action of IP6.
Insights
Inositol hexaphosphate (IP6) significantly reduces cancer cell proliferation by decreasing S-phase and arresting cells in G0/G1. This natural compound disengages cancer cells from active cycling, revealing its anti-neoplastic potential.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Inositol hexaphosphate (IP6) exhibits significant anti-cancer properties in preclinical models.
- Understanding the mechanisms of IP6's anti-neoplastic effects is crucial for therapeutic development.
Purpose of the Study:
- To investigate the impact of IP6 on cell cycle progression in human breast (MCF-7, MDA-MB 231) and colon (HT-29) cancer cell lines.
- To elucidate how IP6 influences cancer cell proliferation at the molecular level.
Main Methods:
- Dual-parameter flow cytometry was used to measure DNA content and 5-bromo-2-deoxyuridine (BrdU) incorporation.
- Expression of cell cycle proteins, Ki-67, and proliferating cell nuclear antigen (PCNA) were analyzed in relation to DNA content.
Main Results:
- IP6 treatment (5 mM, 3 days) significantly decreased S-phase progression (BrdU uptake) in all tested cell lines (p = 0.002).
- MCF-7 and HT-29 cells accumulated in the G0/G1 phase, while MDA-MB 231 cells showed transient G0/G1 accumulation.
- IP6 significantly reduced the expression of proliferation markers Ki-67 and PCNA across all cell lines (p < 0.0001).
Conclusions:
- IP6 effectively controls cancer cell cycle progression by inhibiting S-phase and inducing G0/G1 arrest.
- The reduction in proliferation markers suggests IP6 disengages cells from active proliferation.
- Further research into cell cycle regulators could enhance understanding of IP6's anti-cancer mechanisms.
More Related Videos
09:01Extraction and Quantification of Soluble, Radiolabeled Inositol Polyphosphates from Different Plant Species using SAX-HPLC
Published on: June 26, 2020
09:22Absolute Quantitation of Inositol Pyrophosphates by Capillary Electrophoresis Electrospray Ionization Mass Spectrometry
Published on: August 13, 2021
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
DNA Damage Can Stall the Cell Cycle
Inhibition of CDK Activity
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...